Sun Pharma Advanced Research Company Limited (SPARC)
₹216.78
INR-2.68(-1.22%)
As of December 6, 2024 10:00:00 AMSun Pharma Advanced Research Company Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹215.49
High: ₹219.87
All time High
The highest price the stock has ever reached since being listed
₹455.30
Price Change 1h
Price change in the last hour of trading
+₹-2.87 +-1.31%
Price Change 1d
Price change over the last trading day
+₹-2.87 +-1.31%
Price Change 1w
Price change over the last week of trading
+₹19.40 +9.83%
Sun Pharma Advanced Research Company Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
7002.54 Cr
About Sun Pharma Advanced Research Company Limited Share
Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
409
CEO
Revenue (2023)
%
Country of Origin
India
Key Highlights
- SPARC Q2 Results | Net loss widens to ₹107 crore, revenue dives 39% to ₹13 crore
- Lower circuit stock: Sun Pharma Advanced share price tanks 5% on ending Proseek study; here's what analyst says | Stock Market News
- Sun Pharma Advanced Research Company Limited's (NSE:SPARC) market cap rose ₹4.5b last week; private companies who hold 46% profited and so did insiders
- Sun Pharma Advanced Research Company's Stock Faces Negative Outlook and Decline
- Sun Pharma Advanced Research Reports ₹107.3 Crore Net Loss in Q2
Sun Pharma Advanced Research Company Limited Resource
FAQs
The current price of Sun Pharma Advanced Research Company Limited is INR 216.78 — it has changed by -1.31% in the past 24 hours. Watch Sun Pharma Advanced Research Company Limited's stock price performance more closely on the chart.
Sun Pharma Advanced Research Company Limited has a market capitalization of 70025355264 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sun Pharma Advanced Research Company Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Sun Pharma Advanced Research Company Limited stocks are traded under the ticker [object Object]
As of December 08, 2024, the company has 409 employees.